SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System
Smith & Nephew introduces the LEGION Hinged Knee System with OXINIUM Technology, elevating knee revision surgery through innovation.
SNN Stock Rises on the Completion of First Case With CATALYSTEM System
Smith & Nephew announces the completion of the first case using the CATALYSTEM Primary Hip System.
This stock is 'boring' but has 'fantastic' risk-reward: Scharf
Eric Lynch from Scharf Investments explains why he likes the non-tech and utilities sectors.
SNN Stock Declines Despite the Launch of Its Patient-Matched Guides
Smith & Nephew announces the launch of its TOTAL ANKLE Patient-Matched Guides to plan and perform total ankle replacement procedures.
Smith & Nephew Delivering On Its Turnaround Promise
The Street has taken notice of Smith & Nephew's turnaround progress, with better than expected revenue and margin results driving share price outperformance. While the ortho business has continued to grow, SNN has continued to lose share in major joints and this is the biggest item on management's to-do list now. Management has identified additional savings opportunities that will help boost margins further, and coupled with improved sales execution, could drive EBITDA to 30% over the next five years.
Smith & Nephew (SNN) Partners InfuSystem for Renasys Edge
Smith & Nephew (SNN) inks a three-year agreement with InfuSystem (INFU) to distribute its RENASYS EDGE negative pressure wound therapy system.
Smith & Nephew (SNN), HOPCo to Enhance Musculoskeletal Care
Smith & Nephew (SNN) announces a collaboration with HOPCo to focus on enhancing solutions for ASC customers, physicians, and patients through the latter's digital health and analytics platforms.
Smith & Nephew shares rise as profit beats market forecast
Smith & Nephew's shares rose 9% on Thursday after the British medical equipment maker's half-year profit beat market forecast, helped by a strong performance in its orthopaedics segment.
Should Value Investors Buy Smith & Nephew SNATS (SNN) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Smith & Nephew's (SNN) CATALYSTEM System Gets FDA Clearance
Smith & Nephew (SNN) announces the receipt of FDA clearance for its new CATALYSTEM Primary Hip System, which is intended to address the demands of primary hip surgery.
Activist Cevian has a stake in medical device company Smith & Nephew. How it may help improve margins
British company Smith & Nephew is already a global leader in medical tech. Cevian could help it boost its profitability.
Smith & Nephew's (SNN) 5% Stake Acquired by Cevian Capital
Smith & Nephew (SNN) eyes future growth as Cevian Capital purchases a 5% stake in the company.
